Description
This section of the guidance outlines the additional requirements for good clinical practices, qualified investigators, and labelling.
Resources
| Name | Format | Description | Link |
|---|---|---|---|
| Guidance on applications for COVID-19 drug clinical trials under the Regulations: Additional requirements | HTML | Open resource | |
| Guidance on applications for COVID-19 drug clinical trials under the Regulations: Additional requirements | HTML | Open resource |